Does complement play a role in bone development and regeneration?

被引:66
作者
Schoengraf, Philipp [1 ]
Lambris, John D. [2 ]
Recknagel, Stefan [1 ]
Kreja, Ludwika [1 ]
Liedert, Astrid [1 ]
Brenner, Rolf E. [4 ]
Huber-Lang, Markus [3 ]
Ignatius, Anita [1 ]
机构
[1] Univ Ulm, Ctr Muskuloskelettal Res, Inst Orthopaed Res & Biomech, D-89081 Ulm, Germany
[2] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] Univ Ulm, Ctr Musculoskeletal Res Ulm, Dept Orthopaed, Div Joint & Connect Tissue Dis, D-89081 Ulm, Germany
[4] Univ Ulm, Ctr Musculoskeletal Res Ulm, Ctr Surg, Dept Traumatol Hand Plast & Reconstruct Surg, D-89075 Ulm, Germany
关键词
Bone; Complement; Inflammation; Mesenchymal stem cells; Osteoblasts; Osteoclasts; PERIPHERAL-BLOOD LEUKOCYTES; PROTEIN-COUPLED RECEPTORS; MESENCHYMAL STEM-CELLS; BLUNT CHEST TRAUMA; 3RD COMPONENT; OSTEOCLAST DIFFERENTIATION; OSTEOBLASTIC CELLS; STROMAL CELLS; IN-VITRO; ENDOCHONDRAL OSSIFICATION;
D O I
10.1016/j.imbio.2012.01.020
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
The skeletal and the immune system are not two independent systems, rather, there are multifaceted and complex interactions between the different cell types of both systems and there are several shared cytokines. As a part of the innate immunity, the complement system was found to be an important link between bone and immunity. Complement proteins appear to be involved in bone development and homeostasis, and specifically influence osteoblast and osteoclast activity. This review describes the complex mutual regulation of the two systems, and indicates some of the negative side effects as a result of inappropriate or excessive complement activation. (C) 2012 Elsevier GmbH. All rights reserved.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 98 条
[1]
AKSAMIT RR, 1981, J IMMUNOL, V126, P2194
[2]
Molecular Intercommunication between the Complement and Coagulation Systems [J].
Amara, Umme ;
Flierl, Michael A. ;
Rittirsch, Daniel ;
Klos, Andreas ;
Chen, Hui ;
Acker, Barbara ;
Brueckner, Uwe B. ;
Nilsson, Bo ;
Gebhard, Florian ;
Lambris, John D. ;
Huber-Lang, Markus .
JOURNAL OF IMMUNOLOGY, 2010, 185 (09) :5628-5636
[3]
Surface-attached PEO in the form of activated pluronic with immobilized factor H reduces both coagulation and complement activation in a whole-blood model [J].
Andersson, J ;
Bexborn, F ;
Klinth, J ;
Nilsson, B ;
Ekdahl, KN .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2006, 76A (01) :25-34
[4]
C3 adsorbed to a polymer surface can form an initiating alternative pathway convertase [J].
Andersson, J ;
Ekdahl, KN ;
Larsson, R ;
Nilsson, UR ;
Nilsson, B .
JOURNAL OF IMMUNOLOGY, 2002, 168 (11) :5786-5791
[5]
Complement proteins are present in developing endochondral bone and may mediate cartilage cell death and vascularization [J].
Andrades, JA ;
Nimni, ME ;
Becerra, J ;
Eisenstein, R ;
Davis, M ;
Sorgente, N .
EXPERIMENTAL CELL RESEARCH, 1996, 227 (02) :208-213
[6]
The molecular understanding of osteoclast differentiation [J].
Asagiri, Masataka ;
Takayanagi, Hiroshi .
BONE, 2007, 40 (02) :251-264
[7]
The C5a Receptor (C5aR) C5L2 Is a Modulator of C5aR-mediated Signal Transduction [J].
Bamberg, Claire E. ;
Mackay, Charles R. ;
Lee, Hyun ;
Zahra, David ;
Jackson, Jenny ;
Lim, Yun Si ;
Whitfeld, Peter L. ;
Craig, Stewart ;
Corsini, Erin ;
Lu, Bao ;
Gerard, Craig ;
Gerard, Norma P. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (10) :7633-7644
[8]
Replicative aging and gene expression in long-term cultures of human bone marrow stromal cells [J].
Banfi, A ;
Bianchi, G ;
Notaro, R ;
Luzzatto, L ;
Cancedda, R ;
Quarto, R .
TISSUE ENGINEERING, 2002, 8 (06) :901-910
[9]
The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization [J].
Bock, D ;
Martin, U ;
Gartner, S ;
Rheinheimer, C ;
Raffetseder, U ;
Arseniev, L ;
Barker, MD ;
Monk, PN ;
Bautsch, W ;
Kohl, J ;
Klos, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (06) :1522-1529
[10]
ANAPHYLATOXIN INACTIVATOR OF HUMAN PLASMA - ITS ISOLATION AND CHARACTERIZATION AS A CARBOXYPEPTIDASE [J].
BOKISCH, VA ;
MULLEREB.HJ .
JOURNAL OF CLINICAL INVESTIGATION, 1970, 49 (12) :2427-&